Lukas Bubendorf
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 66
- Oncology top 0.2%
- Lung Cancer Research Studies 27
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 85
- Prostate Cancer Treatment and Research 65
- Prostate Cancer Diagnosis and Treatment 35
- Lung Cancer Diagnosis and Treatment 25
- Molecular Biology top 0.5%
- Immunology and Allergy top 1%
-
- Bladder and Urothelial Cancer Treatments 45
- Urinary and Genital Oncology Studies 28
- Co-authors
- Guido SauterMichael J. MihatschJuha KononenPeter SchramlThomas C. GasserHolger MochJ. TorhorstMaarit Bärlund
- Journals
- Lung Cancer (14 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (11 papers)The Journal of Pathology (11 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Lukas Bubendorf
314 papers receiving 17.0k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 4.0k
- Oncology 6.8k
- Pulmonary and Respiratory Medicine 6.4k
- Molecular Biology 8.3k
- Immunology and Allergy 487
Countries citing papers authored by Lukas Bubendorf
This map shows the geographic impact of Lukas Bubendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Bubendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Bubendorf more than expected).
Fields of papers citing papers by Lukas Bubendorf
This network shows the impact of papers produced by Lukas Bubendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Bubendorf. The network helps show where Lukas Bubendorf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lukas Bubendorf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 1 | |
| 13 | 2020 | 17 | |
| 14 | 2019 | 5 | |
| 15 | 2013 | 67 | |
| 16 | 2011 | 90 | |
| 17 | 2011 | 167 | |
| 18 | Zytologie der ableitenden Harnwege: Zwischen Zweifel und Gewissheit | 2009 | 2 |
| 19 | 2008 | 88 | |
| 20 | Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. | 1997 | 88 |
About Lukas Bubendorf
Lukas Bubendorf is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Urology and Immunology and Allergy, having authored 326 papers that have together received 17.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (85 papers), Cancer Genomics and Diagnostics (66 papers), Prostate Cancer Treatment and Research (65 papers), Bladder and Urothelial Cancer Treatments (45 papers), Prostate Cancer Diagnosis and Treatment (35 papers), Urinary and Genital Oncology Studies (28 papers), Lung Cancer Research Studies (27 papers) and Lung Cancer Diagnosis and Treatment (25 papers). The work is most often cited by research in Cancer Research (4.0k citations), Oncology (6.8k citations), Pulmonary and Respiratory Medicine (6.4k citations), Molecular Biology (8.3k citations) and Immunology and Allergy (487 citations). Lukas Bubendorf has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Guido Sauter, Michael J. Mihatsch, Juha Kononen, Peter Schraml, Thomas C. Gasser, Holger Moch, J. Torhorst, Maarit Bärlund, Stephen B. Leighton and Niels Willi. Their work appears in journals such as Lung Cancer, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, The Journal of Pathology, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.